Skip to main content
Premium Trial:

Request an Annual Quote

Vin Miles, Kelli Richard

Premium
Abingworth, a life sciences investment group, recently announced the appointment of Vin Miles as venture partner.
 
Miles, the former senior vice president of business development at Alnylam Pharmaceuticals, will be responsible for evaluating new investment opportunities and supporting portfolio companies on the East coast, Abingworth said.
 

 
Invitrogen has appointed Kelli Richard vice president of finance and chief accounting officer.
 
Before joining Invitrogen in 2005, Richard spent 14 years in accounting and financial reporting, and was vice president of accounting and reporting and a principal accounting officer at Gateway.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.